Thank you for your interest in post-marketing study information. The Post-Marketing Study Registration System on this website has ceased updates as of January 1, 2025, and related information is no longer provided on this platform.

For inquiries about post-marketing studies or related research information, we recommend exploring other resources that provide clinical trial information, such as the Taiwan Clinical Trials (TaiwanClinicalTrials.tw), clinical trial centers at major hospitals, or the website of Center for Drug Evaluation (https://www1.cde.org.tw/ct_taiwan/introduction.html).

We appreciate your understanding and continued support!

Company Name	Title of Study	Update Date
Bayer Taiwan Co., Ltd.	OPTIMIS - Outcomes of HCC patients treated with TACE followed or not followed by sorafenib and the influence of timing to initiate sorafenib	2018-09-18
Bayer Taiwan Co., Ltd.	RIFTOS - Radioactive Iodine reFractory asymptomatic patients in differentiated Thyroid cancer – an Observational Study to assess the use of MultiKinase Inhibitors	2017-01-26
Bayer Taiwan Co., Ltd.	Xarelto Evidence in Real Life of Patients Preference and Satisfaction Study (X-PRESS)	2017-01-26
Johnson & Johnson Pte Ltd	A multicenter, prospective, longitudinal registry of patients with prostate cancer in Asia	2017-01-26
Astellas Pharma Taiwan, Inc.	GLOBAL MULTICENTRE KIDNEY TRANSPLANT ADVAGRAFTM CONVERSION REGISTRY. A NON-INTERVENTIONAL POST-AUTHORISATION STUDY (PAS)	2017-01-26
Astellas Pharma Taiwan, Inc.	An open-label, randomized, parallel study to evaluate the clinical efficacy and safety of tamsulosin alone or in combination with solifenacin for the treatment in men with lower urinary tract symptoms including overactive bladder symptoms	2017-01-26
Pfizer Inc.	An Observational Study of Xeljanz® (tofacitinib citrate) and Biologic Rheumatoid Arthritis Treatments to Characterize their General Treatment Patterns, Effectiveness and Safety in a Real-World Taiwanese Population	2017-01-26
Astellas Pharma Taiwan, Inc.	A Multi-center, Randomized, Open-label, Pilot and Exploratory Study Investigating Safety and Efficacy in OPTIMIZEd Dosing of Advagraf® Kidney Transplantation in Asia.	2017-01-26
Novartis (Taiwan) Co., Ltd	A 48-week, observational, longitudinal multicenter study on the effectiveness of 9.5 mg/24 h (10 cm2)Exelon in patients with mild to moderate dementia of the Alzheimer's type	2017-01-26
Novartis (Taiwan) Co., Ltd.	A Prospective, Non-interventional, Multi-center, Surveillance Study to Observe the Tolerability of Exjade® (Deferasirox) in Patients with Myelodysplastic Syndrome (MDS) for Chronic Transfusion-Related Iron Overload	2016-01-06